Literature DB >> 14693769

Association between posterior uveal melanoma and iris freckles, iris naevi, and choroidal naevi.

J W Harbour1, M A Brantley, H Hollingsworth, M Gordon.   

Abstract

AIM: To investigate the association between posterior uveal melanoma and iris freckles, iris naevi, and choroidal naevi.
METHODS: Cross sectional study of 65 patients with posterior uveal melanoma and 218 controls. Iris colour, iris freckles, iris naevi, and choroidal naevi were recorded for each eye of each patient.
RESULTS: Iris freckles were present in 40 (61.5%) patients with melanoma and 135 (61.9%) controls (p = 0.494). Iris naevi were present in four (6.2%) patients with melanoma and nine (4.1%) controls (p = 0.955). Choroidal naevi were present in 12 (18.5%) patients with melanoma and 38 (17.4%) controls (p = 0.815).
CONCLUSION: This study did not detect an association between posterior uveal melanoma and iris freckles, iris naevi, or choroidal naevi.

Entities:  

Mesh:

Year:  2004        PMID: 14693769      PMCID: PMC1771959          DOI: 10.1136/bjo.88.1.36

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  18 in total

1.  Pigment Freckles of the Iris (Benign Melanomas): Their Significance in Relation to Malignant Melanoma of the Uvea.

Authors:  A B Reese
Journal:  Trans Am Ophthalmol Soc       Date:  1943

2.  Epidemiology of intraocular melanoma.

Authors:  M A Tucker; P Hartge; J A Shields
Journal:  Recent Results Cancer Res       Date:  1986

3.  Benign nevi and malignant melanomas of the choroid.

Authors:  J P Ganley; G W Comstock
Journal:  Am J Ophthalmol       Date:  1973-07       Impact factor: 5.258

4.  Benign melanomas (nevi) of the choroid and ciliary body.

Authors:  P N Hale; R A Allen; B R Straatsma
Journal:  Arch Ophthalmol       Date:  1965-10

5.  Sunlight and risk of uveal melanoma.

Authors:  E P Horn; P Hartge; J A Shields; M A Tucker
Journal:  J Natl Cancer Inst       Date:  1994-10-05       Impact factor: 13.506

6.  Melanomas of the eye and other noncutaneous sites: epidemiologic aspects.

Authors:  J Scotto; J F Fraumeni; J A Lee
Journal:  J Natl Cancer Inst       Date:  1976-03       Impact factor: 13.506

7.  Relationship of iris nevi to malignant melanoma of the uvea.

Authors:  J B Michelson; J A Shields
Journal:  Am J Ophthalmol       Date:  1977-05       Impact factor: 5.258

8.  Naevi and pigmentary characteristics as risk factors for melanoma in a high-risk population: a case-control study in New South Wales, Australia.

Authors:  A E Grulich; V Bataille; A J Swerdlow; J A Newton-Bishop; J Cuzick; P Hersey; W H McCarthy
Journal:  Int J Cancer       Date:  1996-08-07       Impact factor: 7.396

Review 9.  Melanoma and sun exposure: an overview of published studies.

Authors:  J M Elwood; J Jopson
Journal:  Int J Cancer       Date:  1997-10-09       Impact factor: 7.396

10.  Risk of ocular melanoma in relation to cutaneous and iris naevi.

Authors:  V Bataille; P Sasieni; J Cuzick; J L Hungerford; A Swerdlow; J A Bishop
Journal:  Int J Cancer       Date:  1995-03-03       Impact factor: 7.396

View more
  4 in total

Review 1.  Don't it make my blue eyes brown: heterochromia and other abnormalities of the iris.

Authors:  I G Rennie
Journal:  Eye (Lond)       Date:  2011-10-07       Impact factor: 3.775

2.  Analysis of iris surface features in populations of diverse ancestry.

Authors:  Melissa Edwards; David Cha; S Krithika; Monique Johnson; Esteban J Parra
Journal:  R Soc Open Sci       Date:  2016-01-13       Impact factor: 2.963

3.  Pterygium concomitant with other ocular surface lesions: Clinical implications and pathogenetic links.

Authors:  Efstathios T Detorakis; George Kymionis; Michael Tsatsos; Demetrios A Spandidos
Journal:  Exp Ther Med       Date:  2015-11-13       Impact factor: 2.447

4.  Epidemiological Study of Uveal Melanoma from US Surveillance, Epidemiology, and End Results Program (2010-2015).

Authors:  Yufeng Xu; Lixia Lou; Yijie Wang; Qi Miao; Kai Jin; Menglu Chen; Juan Ye
Journal:  J Ophthalmol       Date:  2020-02-19       Impact factor: 1.909

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.